Comparison
1p35 2 Microdeletion Syndrome vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 1p35 2 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
1p35 2 Microdeletion Syndrome
0-null
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
1p35 2 Microdeletion Syndrome
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
1p35 2 Microdeletion Syndrome
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
1p35 2 Microdeletion Syndrome
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
1p35 2 Microdeletion Syndrome
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
1p35 2 Microdeletion Syndrome
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
1p35-2-microdeletion-syndrome-C5679992 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1p35 2 Microdeletion Syndrome | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Chromosomal region | Involves 1p35.2; a detailed phenotype is not established here. | Involves 13q12.3 and is described as a small missing segment. | High |
| Reported severity class | The supplied axis lists severe, but this is not independently verified. | The supplied description lists moderate severity. | Moderate |
| Developmental or medical features | Specific symptoms or complications are not established in the source. | Developmental and medical concerns are mentioned without a fixed pattern. | Low |
When to favor each condition
Choose 1p35 2 Microdeletion Syndrome when
A confirmed copy-number loss at 1p35.2
The chromosomal locus defines this entity more reliably than a severity label.
High
An unexplained congenital presentation under genetics review
Consider it only when testing implicates 1p35.2 rather than another region.
Moderate
Counseling based only on sparse records
Do not assume a severe course or specific features from the supplied axis alone.
Moderate
Choose 13q12 3 Microdeletion Syndrome C4750951 when
A confirmed copy-number loss at 13q12.3
The 13q12.3 region distinguishes it from a 1p35.2 finding.
High
Need for supportive, individualized congenital care
The source describes variable developmental and medical concerns with tailored support.
Moderate
Interpretation of a moderate-severity label
Use the label cautiously and confirm the actual findings with a clinician.
Moderate
How key tests differ
| Test | 1p35 2 Microdeletion Syndrome | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify copy-number loss involving 1p35.2. | May identify copy-number loss involving 13q12.3. | The region distinguishes them; results require genetics review. |
| Karyotype | May be normal if the deletion is below microscopic resolution. | May likewise be normal for a small deletion. | A normal karyotype does not exclude either finding. |
| Targeted gene panel | May miss a chromosomal deletion if copy number is not assessed. | Has the same limitation for 13q12.3. | A negative panel neither establishes nor excludes these conditions. |
Prognosis comparison
1p35 2 Microdeletion Syndrome
- Outcome
- Long-term outcome is not established from the supplied data.
- Factors
- Reported severe classification and any confirmed individual findings.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- A chronic course with variable developmental or medical needs is possible.
- Factors
- Reported moderate classification and the person's specific findings.
Time frame: Lifelong follow-up may be relevant; the exact course is not established.
Deleted region, associated findings, available support, and clinician review.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Specific developmental complications are not established. Developmental concerns may occur, but their pattern varies. Assess each person rather than inferring a syndrome-wide course. |
| Associated congenital anomalies | Organ involvement is not established from the supplied data. Medical concerns are possible but not specified here. Use medical records and examination, not the comparison alone. |
| Care complexity | A severe label is supplied, but individual needs remain uncertain. Moderate severity and supportive care are described. Severity labels do not predict complications or treatment. |
Patient education highlights
- HighGenetic confirmation
The diagnosis depends on which chromosomal region is missing and should be confirmed by a genetics clinician.
- HighNot contagious
Neither condition is communicable; they are congenital genetic findings.
- MediumSupportive care
Care is individualized. No treatment dose or guaranteed outcome can be inferred from these data.